# Role of Coenzyme Q10 in Chronic Kidney Disease

> **NCT05942027** · PHASE4 · RECRUITING · sponsor: **Tanta University** · enrollment: 44 (estimated)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **DRUG:** Placebo
- **DRUG:** Co-Enzyme Q10

## Key facts

- **NCT ID:** NCT05942027
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-15
- **Primary completion:** 2026-07-14
- **Final completion:** 2026-07-15
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2025-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05942027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05942027, "Role of Coenzyme Q10 in Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05942027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*